Education
About Us
Working with TipRanks
Follow Us
Bioventix PLC (GB:BVXP)
LSE:BVXP
BVXP Stock Chart & Stats
1850.00p
56.00p(1.70%)
At close: 4:00 PM EST
1850.00p
56.00p(1.70%)
Day’s Range― - ―
52-Week Range2,199.00p - 4,000.00p
Previous CloseN/A
Volume24.00
Average Volume (3M)7.85K
Market Cap
£95.88M
Enterprise Value163.03M
Total Cash (Recent Filing)£5.14M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)12.6
Beta0.53
Next Earnings
Mar 30, 2026EPS EstimateN/A
Last Dividend Ex-Date
Apr 10, 2025Dividend Yield6.75%
Share Statistics
EPS (TTM)0.72
Shares Outstanding5,224,860
10 Day Avg. Volume9,152
30 Day Avg. Volume7,851
Financial Highlights & Ratios
PEG Ratio-7.57
Price to Book (P/B)19.03
Price to Sales (P/S)16.78
P/FCF Ratio27.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Bioventix News
BVXP FAQ
What was Bioventix PLC’s price range in the past 12 months?
Bioventix PLC lowest share price was 2199.00p and its highest was 4000.00p in the past 12 months.
What is Bioventix PLC’s market cap?
Bioventix PLC’s market cap is £95.88M.
When is Bioventix PLC’s upcoming earnings report date?
Bioventix PLC’s upcoming earnings report date is Mar 30, 2026 which is in 150 days.
How were Bioventix PLC’s earnings last quarter?
Bioventix PLC released its earnings results on Oct 27, 2025. The company reported 0.72p earnings per share for the quarter, missing the consensus estimate of 0.78p by -0.06p.
Is Bioventix PLC overvalued?
According to Wall Street analysts Bioventix PLC’s price is currently Overvalued.
Does Bioventix PLC pay dividends?
Bioventix PLC pays a Semiannually dividend of 70p which represents an annual dividend yield of 6.75%. See more information on Bioventix PLC dividends here
What is Bioventix PLC’s EPS estimate?
Bioventix PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bioventix PLC have?
Bioventix PLC has 5,224,860 shares outstanding.
What happened to Bioventix PLC’s price movement after its last earnings report?
Bioventix PLC reported an EPS of 0.72p in its last earnings report, missing expectations of 0.78p. Following the earnings report the stock price went down -15.699%.
Which hedge fund is a major shareholder of Bioventix PLC?
Currently, no hedge funds are holding shares in GB:BVXP
Bioventix Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
GB:BVXP Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth £11.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.51%
12-Months-Change
Fundamentals
Return on Equity
64.40%
Trailing 12-Months
Asset Growth
-1.05%
Trailing 12-Months
Company Description
Bioventix PLC
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in London, the United Kingdom.
Technical Analysis
Avacta Group plc
―
Oxford BioDynamics
―
Scancell Holdings
―
4basebio UK Societas
―
Arecor Therapeutics PLC
―
Options Prices
Currently, No data available
---